This transgenic mouse model of AD features high levels of Aβ overexpression, which result from the introduction human APP with two mutations (the Swedish and Indiana mutations i.e., APPSwe/Ind) linked to familial AD (Mucke et al., 2000). The gene discussed is APP; the disease is Alzheimer disease.